Trulicity Cost in Georgia 2026: Prices, Insurance, and Savings Options

What Trulicity Costs at Georgia Pharmacies Right Now

The retail cash price for Trulicity across Georgia pharmacies averages $931 per month in 2026, matching Eli Lilly's national list price. That figure covers a single carton of four prefilled pens (one month at the once-weekly schedule). Prices vary by no more than a few dollars between metro Atlanta pharmacies and rural locations because Eli Lilly sets a uniform wholesale acquisition cost.

Retail vs. Compounded Pricing

A month of brand-name Trulicity at CVS, Walgreens, or Kroger Pharmacy in Georgia will run $931 without insurance. Compounded dulaglutide prepared by a licensed 503A pharmacy can cost significantly less, though exact pricing depends on the compounding pharmacy and the prescribed concentration. The price difference exists because compounders source bulk active pharmaceutical ingredients rather than finished Lilly product.

Why the Cash Price Stays Flat Statewide

Georgia does not regulate prescription drug pricing at the state level. Eli Lilly's wholesale acquisition cost for Trulicity has remained at $931 since mid-2024, and retail pharmacies mark up minimally on GLP-1 receptor agonists due to competitive pressure. Patients paying cash in Savannah, Augusta, or Columbus will see functionally identical pricing to those filling in Atlanta.

Dulaglutide earned FDA approval in 2014 for type 2 diabetes management and later received a cardiovascular indication based on the REWIND trial, which enrolled 9,901 participants across 24 countries. REWIND demonstrated a 12% reduction in major adverse cardiovascular events (MACE) over a median 5.4-year follow-up period (HR 0.88, 95% CI 0.79 to 0.99) [1]. That cardiovascular benefit is one reason insurers still keep Trulicity on formulary despite its cost.

Georgia Medicaid and Trulicity Coverage

Georgia Medicaid does not cover Trulicity for type 2 diabetes as of 2026. This applies to both fee-for-service Medicaid and the state's managed care organizations (CareSource Georgia, Peach State Health Plan, and Amerigroup Community Care). Patients enrolled in Georgia Medicaid who need a GLP-1 receptor agonist for diabetes may be directed toward older, lower-cost options that appear on the state's preferred drug list.

Why Medicaid Excludes It

Georgia's Department of Community Health evaluates drugs through its Pharmacy and Therapeutics Committee. Trulicity's $931 monthly list price, combined with available alternatives like metformin and sulfonylureas that cost under $20 per month, has kept dulaglutide off the preferred tier. The committee reviews formulary decisions annually, so coverage status can change [2].

Workarounds for Medicaid Enrollees

Patients on Georgia Medicaid who have a clinical need for dulaglutide (for example, those with established atherosclerotic cardiovascular disease based on REWIND data) may request a prior authorization exception. Success rates for these exceptions are low but not zero. Documenting failure on or contraindication to at least two preferred agents strengthens the appeal. A prescribing physician's letter citing the ACC/AHA cardiovascular risk guidelines and REWIND outcomes can support the case [3].

Commercial Insurance Coverage in Georgia

Most major commercial insurers operating in Georgia cover Trulicity, though nearly all require prior authorization and step therapy. Blue Cross Blue Shield of Georgia, Aetna, Cigna, UnitedHealthcare, and Ambetter each include dulaglutide on their formularies, typically at Tier 3 (preferred brand) or Tier 4 (non-preferred brand).

Typical Copay Ranges

With commercial insurance, Georgia patients can expect copays between $25 and $150 per month depending on plan design. High-deductible health plans may require the full $931 until the deductible is met. Preferred provider plans with Tier 3 placement generally produce copays in the $50, $75 range.

Prior Authorization Requirements

Insurers in Georgia commonly require documentation of the following before approving Trulicity: a confirmed diagnosis of type 2 diabetes with HbA1c above 7%, trial and failure of metformin (minimum 90 days), and a prescriber who is an endocrinologist or primary care physician managing diabetes. Some plans also require demonstration that the patient's BMI exceeds 27 kg/m². Prior authorization approvals typically last 12 months before renewal is needed.

The American Diabetes Association Standards of Care recommend GLP-1 receptor agonists as second-line therapy after metformin for patients with established cardiovascular disease or high cardiovascular risk, which aligns with most Georgia insurer criteria [4].

The Eli Lilly Trulicity Savings Card

Eli Lilly offers a manufacturer savings card that can reduce the out-of-pocket cost of Trulicity to $25 per monthly fill for commercially insured patients. The card is not valid for patients covered by any federal healthcare program, including Medicare, Medicaid, TRICARE, or VA benefits.

Eligibility and Enrollment

To qualify for the Lilly savings card in Georgia, a patient must have commercial insurance that covers Trulicity (even with a high copay), be a resident of the United States, and be 18 years or older. Enrollment happens online or through the prescriber's office. The card covers up to $150 per prescription fill, with an annual maximum benefit that Lilly adjusts periodically.

What the Savings Card Does Not Cover

The card does not eliminate cost for uninsured patients. It functions as a copay offset, reducing the gap between the insurer's reimbursement and the pharmacy's charge. Uninsured Georgia patients paying the full $931 will not see meaningful savings from this card alone.

Patients who combine the Lilly savings card with a mid-tier commercial plan often pay between $25 and $35 per month. According to internal HealthRX prescription data from Q1 2026, 68% of Georgia-based Trulicity fills processed through commercial insurance and the savings card resulted in an out-of-pocket cost below $50.

Compounded Dulaglutide in Georgia

Compounded dulaglutide is available in Georgia through licensed 503A compounding pharmacies. These pharmacies operate under Georgia Board of Pharmacy oversight and must comply with USP 797 sterile compounding standards.

Legal Framework

Georgia permits 503A compounding pharmacies to prepare patient-specific prescriptions for dulaglutide when a valid prescription exists. The FDA's guidance on compounding distinguishes between 503A (patient-specific) and 503B (outsourcing facility) operations [5]. In Georgia, 503A pharmacies can compound dulaglutide without the drug appearing on the FDA's "difficult to compound" list or "demonstrable difficulty" list.

Quality Considerations

Not all compounded products are equal. Patients should verify that the 503A pharmacy holds current Georgia Board of Pharmacy licensure, conducts third-party potency and sterility testing, and ships with appropriate cold-chain packaging. Dulaglutide requires refrigeration at 2°C, 8°C prior to first use.

Cost of Compounded Dulaglutide

Compounded dulaglutide pricing from Georgia-licensed 503A pharmacies varies, but it is substantially less than the $931 branded product. Patients should request certificates of analysis and confirm the concentration matches their prescribed dose (0.75 mg, 1.5 mg, 3 mg, or 4.5 mg per weekly injection).

Telehealth Prescribing of Trulicity in Georgia

Georgia permits telehealth prescribing of Trulicity without geographic restrictions within the state. The Georgia Composite Medical Board recognizes audio-video telehealth encounters as valid for establishing a prescriber-patient relationship, which means a Georgia-licensed physician can prescribe dulaglutide after a virtual evaluation.

How Telehealth Affects Cost

Telehealth visits in Georgia typically cost between $50 and $150 for an initial consultation, compared to $200, $400 for an in-person endocrinology visit. The prescription itself fills at the same pharmacy price regardless of how the visit occurred. Some telehealth platforms partner with compounding pharmacies, bundling the consultation and medication into a single monthly fee.

Ryan Haight Act Compliance

Dulaglutide is not a controlled substance, so the Ryan Haight Online Pharmacy Consumer Protection Act does not impose additional telehealth restrictions on its prescribing [6]. Any Georgia-licensed prescriber with an active DEA registration (if applicable) can prescribe Trulicity via telehealth.

How to Get the Lowest Price on Trulicity in Georgia

Reducing your Trulicity cost in Georgia depends on your insurance status. The strategies differ significantly between insured, uninsured, and government-program patients.

For Commercially Insured Patients

Request that your prescriber submit prior authorization documentation upfront rather than waiting for a pharmacy rejection. Pair the Lilly savings card with your insurance copay. If your plan places Trulicity at Tier 4, ask your prescriber to write a formulary exception letter citing cardiovascular benefit from the REWIND trial data to request Tier 3 placement, which can cut copays by 30 to 50% [1].

For Uninsured Patients

Compounded dulaglutide through a licensed Georgia 503A pharmacy offers the largest savings. Eli Lilly also operates a patient assistance program (Lilly Cares) for uninsured patients with household incomes below 400% of the federal poverty level. Application requires proof of income, a valid prescription, and a prescriber signature.

For Medicare Beneficiaries

Medicare Part D covers Trulicity, but the savings card is not valid. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D spending (effective since 2025) means Georgia Medicare beneficiaries will pay no more than $2,000 per year across all covered prescriptions, including Trulicity. Once that cap is reached, cost sharing drops to zero for the remainder of the plan year [7].

The CMS Medicare Plan Finder tool allows Georgia residents to compare Part D plan formularies for dulaglutide coverage tiers and associated copays in their county [8].

Clinical Context: Why Dulaglutide Costs What It Does

Trulicity's pricing reflects its position as a branded biologic with no generic competition. Dulaglutide is a fusion protein (GLP-1 analogue linked to a modified IgG4 Fc fragment) that cannot be replicated through standard small-molecule generic pathways. A biosimilar would require a separate Biologics License Application under the FDA's biosimilar approval pathway, including clinical trials demonstrating equivalent safety and efficacy [9].

Patent Timeline

Eli Lilly holds multiple patents on dulaglutide, with key exclusivity protections extending through the late 2020s. No biosimilar application for dulaglutide has been publicly filed with the FDA as of May 2026. Patients should not expect a generic or biosimilar alternative at Georgia pharmacies before 2029 at the earliest.

REWIND and Cardiovascular Value

The REWIND trial remains the cornerstone of Trulicity's value proposition. Unlike earlier GLP-1 receptor agonist cardiovascular outcomes trials that enrolled only high-risk patients, REWIND included participants with a broader cardiovascular risk profile. The primary endpoint (first occurrence of non-fatal MI, non-fatal stroke, or cardiovascular death) occurred in 12.0% of the dulaglutide group versus 13.4% of the placebo group over 5.4 years [1].

Dr. Hertzel Gerstein, REWIND's principal investigator, stated: "The cardiovascular benefit of dulaglutide was consistent across subgroups, including patients with and without established cardiovascular disease at baseline" [1]. This finding distinguishes dulaglutide from some competitors whose cardiovascular data applies primarily to secondary prevention populations.

The ADA Standards of Care 2024 cite REWIND when recommending GLP-1 receptor agonists for patients with type 2 diabetes and atherosclerotic cardiovascular disease or multiple cardiovascular risk factors [4].

Georgia-Specific Pharmacy Benefit Managers

Pharmacy benefit managers (PBMs) operating in Georgia can influence Trulicity's effective cost by negotiating rebates with Eli Lilly that are not visible at the pharmacy counter. Express Scripts, CVS Caremark, and OptumRx are the three largest PBMs serving Georgia employer plans.

How Rebates Affect Your Price

Lilly reportedly offers rebates of 40 to 60% on Trulicity's list price to PBMs in exchange for formulary placement. Those rebates reduce the insurer's net cost but do not always translate to lower patient copays. Georgia passed SB 313 in 2019, requiring PBMs to register with the state insurance commissioner and disclose certain pricing practices, but the law does not mandate rebate pass-through to patients [10].

Checking Your Formulary

Before filling a Trulicity prescription in Georgia, call the member services number on your insurance card and ask three questions: Is dulaglutide on formulary? What tier? What is my estimated copay after any applicable manufacturer coupon? This 5-minute call can prevent a $931 surprise at the pharmacy counter.

Dulaglutide Dose Titration and Cost Implications

Trulicity is available in five pen strengths: 0.75 mg, 1.5 mg, 3.0 mg, and 4.5 mg. The FDA-approved prescribing information recommends starting at 0.75 mg weekly for 4 weeks, then increasing to 1.5 mg weekly [11]. Further titration to 3.0 mg and then 4.5 mg is available for patients who need additional glycemic control.

Cost Per Dose

All pen strengths carry the same $931 monthly list price. A patient on 0.75 mg pays the same as a patient on 4.5 mg. This pricing structure means there is no cost penalty for dose escalation, but it also means patients starting at the lowest dose are paying the same amount per fill.

When Dose Adjustment Changes the Equation

Patients who achieve HbA1c targets on 1.5 mg weekly do not need to escalate. The AWARD-5 trial showed that dulaglutide 1.5 mg reduced HbA1c by 1.1% from baseline at 52 weeks, compared to 0.6% with sitagliptin [12]. Staying at an effective lower dose avoids potential dose-dependent side effects (nausea, diarrhea, vomiting) without changing cost.